Ga onbeperkt met Magzter GOLD

Ga onbeperkt met Magzter GOLD

Krijg onbeperkte toegang tot meer dan 9000 tijdschriften, kranten en Premium-verhalen voor slechts

$149.99
 
$74.99/Jaar
The Perfect Holiday Gift Gift Now

MIND-ALTERING KETAMINE BECOMES NEW PAIN TREATMENT, DESPITE LITTLE RESEARCH OR REGULATION

AppleMagazine

|

AppleMagazine #628

As U.S. doctors scale back their use of opioid painkillers, a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a trendy psychedelic therapy.

MIND-ALTERING KETAMINE BECOMES NEW PAIN TREATMENT, DESPITE LITTLE RESEARCH OR REGULATION

Prescriptions for ketamine have soared in recent years, driven by for-profit clinics and telehealth services offering the medication as a treatment for pain, depression, anxiety and other conditions. The generic drug can be purchased cheaply and prescribed by most physicians and some nurses, regardless of their training.

With limited research on its effectiveness against pain, some experts worry the U.S. may be repeating mistakes that gave rise to the opioid crisis: overprescribing a questionable drug that carries significant safety and abuse risks.

"There's a paucity of options for pain and so there's a tendency to just grab the next thing that can make a difference," said Dr. Padma Gulur, a Duke University pain specialist who is studying ketamine's use. "A medical journal will publish a few papers saying, 'Oh, look, this is doing good things, and then there's rampant off-label use, without necessarily the science behind it."

When Gulur and her colleagues tracked 300 patients receiving ketamine at Duke, more than a third of them reported significant side effects that required professional attention, such as hallucinations, troubling thoughts and visual disturbances.

Ketamine also didn't result in lower rates of opioid prescribing in the months following treatment, a common goal of therapy, according to Gulur. Her research is under review for medical journal publication.

PSYCHEDELIC EXPERIENCE

Ketamine was approved more than 50 years ago as a powerful anesthetic for patients undergoing surgery. At lower doses, it can produce psychedelic, out-of-body experiences, which made it a popular club drug in the 1990s. With its recent adoption for pain, patients are increasingly encountering those same effects..

MEER VERHALEN VAN AppleMagazine

AppleMagazine

AppleMagazine

APPLE MUSIC IS COMING TO CHATGPT AS OPENAI ANNOUNCES NEW INTEGRATION

Apple Music is set to integrate with ChatGPT, expanding how users can discover and interact with music through conversational artificial intelligence.

time to read

4 mins

December 19, 2025

AppleMagazine

AppleMagazine

DATA CENTERS IN ORBIT AND THE LIMITS OF SPACE-BASED COMPUTING

The idea of placing data centers in space has moved from science fiction into serious discussion among aerospace companies, cloud providers, and artificial intelligence researchers.

time to read

5 mins

December 19, 2025

AppleMagazine

AppleMagazine

APPLE FITNESS+ EXPANDS TO 28 ADDITIONAL COUNTRIES

Apple has extended the availability of its Fitness+ subscription service to 28 additional countries, broadening the geographic reach of one of the company's most tightly integrated digital services.

time to read

4 mins

December 19, 2025

AppleMagazine

AppleMagazine

New Leaders

THE PATH THAT COULD DEFINE APPLE'S NEXT CHAPTER

time to read

6 mins

December 19, 2025

AppleMagazine

AppleMagazine

APPLE PATCHES TWO ZERO-DAY IOS FLAWS USED IN TARGETED ATTACKS

Apple has released security updates addressing two previously unknown vulnerabilities that the company said were actively exploited in what it described as sophisticated attacks.

time to read

3 mins

December 19, 2025

AppleMagazine

AppleMagazine

INTERNAL IOS SOFTWARE LEAK SURFACES DETAILS ON UPCOMING APPLE FEATURES

An internal Apple software leak has revealed a broad snapshot of features and system changes under development for future versions of iOS, offering an unusually detailed look at how the company is evolving its mobile platform behind closed doors.

time to read

4 mins

December 19, 2025

AppleMagazine

AppleMagazine

AIRPODS MAX 2 RUMORS POINT TO CHIP UPGRADE AND NEW AUDIO FEATURES

Apple's AirPods Max turned five years old this week, and a new roundup of rumors has outlined what a second-generation model could add if Apple refreshes its over-ear headphones on a longer cycle than the standard AirPods lineup.

time to read

4 mins

December 19, 2025

AppleMagazine

AppleMagazine

AI USAGE AT WORK HAS DOUBLED AS ADOPTION EXPANDS ACROSS PROFESSIONS

Artificial intelligence use in the workplace has risen sharply in recent years, with surveys showing that a much larger share of workers now report using Al tools in their daily roles compared with just a few years ago.

time to read

4 mins

December 19, 2025

AppleMagazine

AppleMagazine

PLURIBUS LEADS APPLE TV VIEWERSHIP FOR A SECOND STRAIGHT WEEK

Apple TV's weekly audience rankings once again place Pluribus at the top of the platform's most-watched chart, according to viewership data tracked across Apple's original programming lineup.

time to read

3 mins

December 19, 2025

AppleMagazine

AppleMagazine

FORD F-150 LIGHTNING STRUGGLES HIGHLIGHT THE CHALLENGES OF ELECTRIC PICKUPS

Ford's experience with the F-150 Lightning has become a case study in how difficult it is to translate electric vehicle momentum into the pickup truck segment.

time to read

3 mins

December 19, 2025

Translate

Share

-
+

Change font size

Holiday offer front
Holiday offer back